کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4001078 1259396 2007 13 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Targeted therapies for kidney cancer in urologic practice
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی تومور شناسی
پیش نمایش صفحه اول مقاله
Targeted therapies for kidney cancer in urologic practice
چکیده انگلیسی

Renal cell carcinoma (RCC) is the most lethal of all genitourinary malignancies with nearly half of all patients presenting with locally advanced or metastatic disease. Systemic treatments such as chemo- or immunotherapy have historically been associated with overall response rates of 5–15% with very few durable responses. The basis of newly approved, more effective targeted therapies for metastatic RCC are based on a fundamental knowledge of the molecular mechanisms that give rise to RCC. We review the clinical data for targeted therapies in RCC and discuss the pertinent biology, side effects, and targets important to the practicing clinician.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Urologic Oncology: Seminars and Original Investigations - Volume 25, Issue 5, September–October 2007, Pages 420–432
نویسندگان
, ,